NCT04979442: A reported trial by Rain Oncology Inc
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04979442 |
|---|---|
| Title | A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients With Dedifferentiated Liposarcoma |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 14, 2021 |
| Completion date | Oct. 1, 2023 |
| Required reporting date | Sept. 30, 2024, midnight |
| Actual reporting date | Aug. 16, 2024 |
| Date last checked at ClinicalTrials.gov | April 7, 2025 |
| Days late | None |